NGMD — NuGen Medical Devices Balance Sheet
0.000.00%
- CA$20.43m
- CA$30.35m
- CA$0.33m
Annual balance sheet for NuGen Medical Devices, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Cash and Short Term Investments | 1.75 | 0.131 | 0.464 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0.311 | 0.243 | 0.355 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 2.15 | 0.567 | 1.33 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 0.018 | 0.163 | 0.031 |
Net Goodwill | |||
Net Intangible Assets | |||
Total Assets | 8.84 | 6.85 | 6.95 |
Accounts Payable | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 1.23 | 1.73 | 3.29 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 7.19 | 9.11 | 9.01 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 1.66 | -2.26 | -2.06 |
Total Liabilities & Shareholders' Equity | 8.84 | 6.85 | 6.95 |
Total Common Shares Outstanding |